PARP1 and non-small cell lung carcinoma: The lncRNA MVIH is involved in drug resistance in NSCLC, and knockdown of MVIH restored drug sensitivity of cancer cells to cisplatin (DDP) by inducing apoptosis via upregulation of caspase-3, caspase-6 and cleaved PARP [23].